Literature DB >> 7040369

Urokinase-like plasminogen activators of unusually high molecular weight secreted by a cell line derived from a human lung cancer case.

S Harvey, J Minowada, H Takita, L Kover, G Markus.   

Abstract

The HPL-SK-1 cell line derived from the pleural exudate of a lung cancer patient has been shown to secrete plasminogen activators of very high molecular weights (greater than or equal to 2 and 1 million), as shown by gel filtration on Sepharose 6B or CL-6B. The size of these activators could not be reduced by chromatography in buffers containing 2% sodium dodecyl sulfate, 8 M urea, or 1 M KSCN. Goat anti-urokinase antibody inhibited these activators only partially. Trypsin digestion of the 2 million-dalton species yielded several active fragments including one of the size of urokinase, 55,000 daltons. These large activators could be purified only by a double antibody immunoadsorption technique which consisted of the formation of a soluble immune complex between the activators and goat anti-urokinase IgG, followed by the adsorption of this complex to rabbit anti-goat IgG coupled to Affi-Gel 10. The eluted activators were purified 50-fold (2 million daltons) and 130-fold (1 million daltons), respectively. Reduction of the two largest species in the presence of sodium dodecyl sulfate resulted in the appearance of smaller molecular weight active fragments of differing size, indicating that these activators are disulfide-linked oligomers. Among the fragments of the 2 million-dalton species was found a 10,000-dalton enzyme which had lost activator and antigenic specificity and retained only a non-specific protease activity. A similar fragment was also isolated from reduced, purified 55,000-dalton urinary urokinase.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7040369

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Urokinase-dependent adhesion loss and shape change after cyclic adenosine monophosphate elevation in cultured rat mesangial cells.

Authors:  W F Glass; R A Radnik; J A Garoni; J I Kreisberg
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

2.  Monoclonal antibodies to human urokinase identify the single-chain pro-urokinase precursor.

Authors:  G Salerno; P Verde; M L Nolli; A Corti; H Szöts; T Meo; J Johnson; S Bullock; G Cassani; F Blasi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

3.  A high-molecular weight complex with acid phosphatase activity in human breast cancer.

Authors:  O L Podhajcer; J E Filmus; N Guman; J Mordoh
Journal:  Mol Cell Biochem       Date:  1984-09       Impact factor: 3.396

4.  Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.

Authors:  N Toki; H Sumi; K Sasaki; I Boreisha; K C Robbins
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

5.  Secretion of plasminogen activators by human colorectal and gastric tumor explants.

Authors:  S R Harvey; D D Lawrence; J M Madeja; S J Abbey; G Markus
Journal:  Clin Exp Metastasis       Date:  1988 Nov-Dec       Impact factor: 5.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.